Testing a new hypertension drug in mild to moderate patients
Part of Heart & circulation clinical trials.
This trial tests a new medicine called IBI3016 for people with mild to moderate high blood pressure. It aims to find the right dose to safely lower blood pressure without other blood pressure medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with primary high blood pressure (not caused by another condition).
- You are not currently taking any blood pressure medication, or you are taking only one.
- Your average seated systolic blood pressure (top number) is between 140 and 169 mmHg.
- You do not have certain health problems like heart, liver, or kidney issues that would interfere with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests a new medication called IBI3016 to help lower blood pressure in people with mild to moderate hypertension who haven't recently taken blood pressure medications. The goal is to see if this drug is safe and effective.
This trial tests a new treatment called CTX340 for high blood pressure that is hard to control even with multiple medications. The study aims to see if it is safe and effective.
This study tests a standard approach to lowering blood pressure in people whose blood pressure is not well controlled with current treatment. It may help find a more effective way to manage hypertension.
This study tests a new combination blood pressure medicine (HCP1803-4) for people with essential hypertension. It aims to see if the medicine works better than current options and is safe for long-term use.
This study tests a new medication (TCA108) for people whose high blood pressure is not well controlled despite taking two blood pressure medicines. The goal is to see if TCA108 can safely lower blood pressure further.
This early-stage trial tests a new blood pressure medication called HJB647 in Japanese adults with elevated or high blood pressure. The study aims to see if the drug is safe and how the body handles it.
Hear when a new High blood pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.